1. Home
  2. GTHX
  3. GTHX News

Latest G1 Therapeutics Inc. (GTHX) News on July 27, 2024

G1 Therapeutics, Inc.'s (NASDAQ:GTHX) top owners are retail investors with 56% stake, while 28% is held by institutions
GTHX

Simply Wall St.

10 hours ago

G1 Therapeutics, Inc.'s (NASDAQ:GTHX) top owners are retail investors with 56% stake, while 28% is held by institutions

G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
GTHX

GlobeNewswire

a day ago

G1 Therapeutics to Release Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024

GTHX

MT Newswires

25 days ago

G1 Therapeutics Joins Russell 3000, Russell 2000 Indexes

G1 Therapeutics Added to the Russell 2000® and 3000® Indexes
GTHX

GlobeNewswire

a month ago

G1 Therapeutics Added to the Russell 2000® and 3000® Indexes

G1 Therapeutics discontinue COSELA in TNBC following Phase III flop
GTHX

Clinical Trials Arena

a month ago

G1 Therapeutics discontinue COSELA in TNBC following Phase III flop

GTHX

MT Newswires

a month ago

Top Midday Decliners

GTHX

MT Newswires

a month ago

Top Premarket Decliners

GTHX

MT Newswires

a month ago

G1 Therapeutics Halts Phase 3 Breast Cancer Drug Trial As Data Disappoints

G1 Therapeutics Provides Update on Phase 3 PRESERVE 2 Trial in Patients Receiving Trilaciclib Prior to First Line Chemotherapy in Metastatic Triple Negative Breast Cancer (mTNBC)
GTHX

GlobeNewswire

a month ago

G1 Therapeutics Provides Update on Phase 3 PRESERVE 2 Trial in Patients Receiving Trilaciclib Prior to First Line Chemotherapy in Metastatic Triple Negative Breast Cancer (mTNBC)

It's Probably Less Likely That G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Will See A Huge Pay Rise This Year
GTHX

Simply Wall St.

2 months ago

It's Probably Less Likely That G1 Therapeutics, Inc.'s (NASDAQ:GTHX) CEO Will See A Huge Pay Rise This Year

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GTHX

GlobeNewswire

2 months ago

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

G1 Therapeutics (NASDAQ:GTHX shareholders incur further losses as stock declines 19% this week, taking three-year losses to 84%
GTHX

Simply Wall St.

2 months ago

G1 Therapeutics (NASDAQ:GTHX shareholders incur further losses as stock declines 19% this week, taking three-year losses to 84%

Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)
GTHX

GlobeNewswire

2 months ago

Meaningful Improvement in Overall Survival (OS) and Tolerability Observed in Patients Receiving Trilaciclib in Combination with a TROP2 Antibody-Drug Conjugate (ADC)

G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting
GTHX

GlobeNewswire

2 months ago

G1 Therapeutics Announces Upcoming Presentation at the 2024 American Society of Clinical Oncology (ASCO) Meeting

G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit
GTHX

GlobeNewswire

2 months ago

G1 Therapeutics to Participate in TD Cowen’s 5th Annual Oncology Innovation Summit

GTHX

MT Newswires

2 months ago

Sector Update: Health Care Stocks Lower Premarket Wednesday

GTHX

MT Newswires

2 months ago

G1 Therapeutics Grants Deimos Biosciences License to Market Anti-Radiation Treatment -- Shares Up Pre-Bell

G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses
GTHX

GlobeNewswire

2 months ago

G1 Therapeutics and Deimos Biosciences Announce Global (Excluding Asia-Pacific) License Agreement for Lerociclib for Radioprotective Uses

G1 Therapeutics, Inc. (NASDAQ:GTHX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
GTHX

Simply Wall St.

3 months ago

G1 Therapeutics, Inc. (NASDAQ:GTHX) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

G1 Therapeutics First Quarter 2024 Earnings: Revenues Disappoint
GTHX

Simply Wall St.

3 months ago

G1 Therapeutics First Quarter 2024 Earnings: Revenues Disappoint

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript
GTHX

Insider Monkey

3 months ago

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q1 2024 Earnings Call Transcript

GTHX

GuruFocus.com

3 months ago

G1 Therapeutics Inc (GTHX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...

GTHX

Thomson Reuters StreetEvents

3 months ago

Q1 2024 G1 Therapeutics Inc Earnings Call

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GTHX

GlobeNewswire

3 months ago

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

G1 Therapeutics Inc (GTHX) Q1 2024 Earnings: Close Alignment with Analyst Revenue Projections
GTHX

GuruFocus.com

3 months ago

G1 Therapeutics Inc (GTHX) Q1 2024 Earnings: Close Alignment with Analyst Revenue Projections

G1 Therapeutics (GTHX) Reports Q1 Loss, Lags Revenue Estimates
GTHX

Zacks

3 months ago

G1 Therapeutics (GTHX) Reports Q1 Loss, Lags Revenue Estimates

G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights
GTHX

GlobeNewswire

3 months ago

G1 Therapeutics Provides First Quarter 2024 Financial Results and Operational Highlights

G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib
GTHX

GlobeNewswire

3 months ago

G1 Therapeutics and Pepper Bio Announce Global (Excluding Asia-Pac) License Agreement for Lerociclib

G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Shift From Loss To Profit
GTHX

Simply Wall St.

3 months ago

G1 Therapeutics, Inc.'s (NASDAQ:GTHX) Shift From Loss To Profit

G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024
GTHX

GlobeNewswire

3 months ago

G1 Therapeutics to Release First Quarter 2024 Financial Results and Provide Business Update on May 1, 2024

G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GTHX

GlobeNewswire

4 months ago

G1 Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GTHX

GlobeNewswire

4 months ago

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GTHX

GlobeNewswire

5 months ago

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript
GTHX

Insider Monkey

5 months ago

G1 Therapeutics, Inc. (NASDAQ:GTHX) Q4 2023 Earnings Call Transcript

GTHX

Thomson Reuters StreetEvents

5 months ago

Q4 2023 G1 Therapeutics Inc Earnings Call

G1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates
GTHX

Zacks

5 months ago

G1 Therapeutics (GTHX) Reports Q4 Loss, Tops Revenue Estimates

G1 Therapeutics Inc (GTHX) Reports Strong Revenue Growth in 2023
GTHX

GuruFocus.com

5 months ago

G1 Therapeutics Inc (GTHX) Reports Strong Revenue Growth in 2023

G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
GTHX

GlobeNewswire

5 months ago

G1 Therapeutics Provides Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights

G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference
GTHX

GlobeNewswire

5 months ago

G1 Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference

G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 47% loss last week hit both individual investors who own 60% as well as institutions
GTHX

Simply Wall St.

5 months ago

G1 Therapeutics, Inc.'s (NASDAQ:GTHX) 47% loss last week hit both individual investors who own 60% as well as institutions

G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024
GTHX

GlobeNewswire

5 months ago

G1 Therapeutics to Release Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on February 28, 2024

G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee
GTHX

GlobeNewswire

5 months ago

G1 Therapeutics to Continue Pivotal Phase 3 Trial of Trilaciclib in Metastatic Triple Negative Breast Cancer Following Interim Analysis by Independent Data Monitoring Committee

Shareholders in Fidelity D & D Bancorp (NASDAQ:FDBC) are in the red if they invested five years ago
GTHX

Simply Wall St.

6 months ago

Shareholders in Fidelity D & D Bancorp (NASDAQ:FDBC) are in the red if they invested five years ago

Forum Energy Technologies Announces Timing of Fourth Quarter and Full Year 2023 Earnings Conference Call
GTHX

Business Wire

6 months ago

Forum Energy Technologies Announces Timing of Fourth Quarter and Full Year 2023 Earnings Conference Call

EV Roundup: STLA Unveils Electrified Platform, FSR Faces NHTSA Scrutiny & More
GTHX

Zacks

6 months ago

EV Roundup: STLA Unveils Electrified Platform, FSR Faces NHTSA Scrutiny & More

GTHX

Investing.com

6 months ago

Midday movers: Alibaba surges, 3M sinks, and more

GTHX

Business Wire

6 months ago

First Trust Senior Floating Rate Income Fund II Declares its Monthly Common Share Distribution of $0.097 Per Share for February

Funko (FNKO) & Goliath Forge Exclusive Global Gaming Alliance
GTHX

Zacks

6 months ago

Funko (FNKO) & Goliath Forge Exclusive Global Gaming Alliance

Zacks Market Edge Highlights: MODG, BALY, FNKO, IIPR and DFIN
GTHX

Zacks

6 months ago

Zacks Market Edge Highlights: MODG, BALY, FNKO, IIPR and DFIN

South Plains Financial, Inc. Declares Quarterly Cash Dividend
GTHX

GlobeNewswire

6 months ago

South Plains Financial, Inc. Declares Quarterly Cash Dividend

Hear from Dale Schwartz, Founder & CEO of Pinstripes Holdings Inc. Live at ICR Conference 2024
GTHX

IPO-Edge.com

6 months ago

Hear from Dale Schwartz, Founder & CEO of Pinstripes Holdings Inc. Live at ICR Conference 2024

3 Breakout Penny Stocks Primed for Massive Gains
GTHX

InvestorPlace

6 months ago

3 Breakout Penny Stocks Primed for Massive Gains

Nkarta, Inc.'s (NASDAQ:NKTX) institutional investors lost 17% last week but have benefitted from longer-term gains
GTHX

Simply Wall St.

6 months ago

Nkarta, Inc.'s (NASDAQ:NKTX) institutional investors lost 17% last week but have benefitted from longer-term gains

Blade Air Mobility to Present at 26th Annual Needham Growth Conference
GTHX

GlobeNewswire

6 months ago

Blade Air Mobility to Present at 26th Annual Needham Growth Conference

IDEAYA Biosciences, Inc. (IDYA) Moves 7.6% Higher: Will This Strength Last?
GTHX

Zacks

6 months ago

IDEAYA Biosciences, Inc. (IDYA) Moves 7.6% Higher: Will This Strength Last?

5 Small-Cap Stocks to Play the January Effect
GTHX

Zacks

7 months ago

5 Small-Cap Stocks to Play the January Effect

Entravision Announces Massive Expansion of Spanish-Language News Coverage
GTHX

Business Wire

7 months ago

Entravision Announces Massive Expansion of Spanish-Language News Coverage

G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference
GTHX

GlobeNewswire

7 months ago

G1 Therapeutics Provides Corporate Update at the 42nd Annual J.P. Morgan Healthcare Conference

GTHX

ACCESSWIRE

7 months ago

iAccess Alpha Tax Loss Recovery Summit 2024 - Buyside Best Ideas January 9th-10th 2024

Resources Connection Inc (RGP) Faces Revenue Decline Amid Economic Challenges in Q2 Fiscal 2024
GTHX

GuruFocus.com

7 months ago

Resources Connection Inc (RGP) Faces Revenue Decline Amid Economic Challenges in Q2 Fiscal 2024

Insider Sell: President and CEO Bailey John E. (Jack) Jr. Sells 32,983 Shares of G1 Therapeutics Inc
GTHX

GuruFocus.com

7 months ago

Insider Sell: President and CEO Bailey John E. (Jack) Jr. Sells 32,983 Shares of G1 Therapeutics Inc

G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
GTHX

GlobeNewswire

7 months ago

G1 Therapeutics to Participate in the 42nd Annual J.P. Morgan Healthcare Conference

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GTHX

GlobeNewswire

7 months ago

G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEUBERGER BERMAN ENERGY INFRASTRUCTURE AND INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION
GTHX

PR Newswire

7 months ago

NEUBERGER BERMAN ENERGY INFRASTRUCTURE AND INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION

Reasons to Add Global Water Resources (GWRS) to Your Portfolio Now
GTHX

Zacks

7 months ago

Reasons to Add Global Water Resources (GWRS) to Your Portfolio Now

12 Countries That Produce The Best Uranium In The World
GTHX

Insider Monkey

7 months ago

12 Countries That Produce The Best Uranium In The World

El Pollo Loco's Delicious Double Pollo Fit™ Bowls Make Triumphant Return In Time to Make New Year Resolution Meal Planning Easier, More Convenient
GTHX

GlobeNewswire

7 months ago

El Pollo Loco's Delicious Double Pollo Fit™ Bowls Make Triumphant Return In Time to Make New Year Resolution Meal Planning Easier, More Convenient

Sezzle Inc. (ASX:SZL) boasts of bullish insider sentiment with 58% ownership and they have been buying lately
GTHX

Simply Wall St.

7 months ago

Sezzle Inc. (ASX:SZL) boasts of bullish insider sentiment with 58% ownership and they have been buying lately

Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration
GTHX

GlobeNewswire

7 months ago

Zevra Therapeutics Announces Resubmission of Arimoclomol New Drug Application to the U.S. Food and Drug Administration

Annexon Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GTHX

GlobeNewswire

7 months ago

Annexon Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference

13 Most Promising Small-Cap Stocks According to Analysts
GTHX

Insider Monkey

7 months ago

13 Most Promising Small-Cap Stocks According to Analysts

Limoneira (LMNR) Q4 2023 Earnings Call Transcript
GTHX

Motley Fool

7 months ago

Limoneira (LMNR) Q4 2023 Earnings Call Transcript

Limoneira Co (LMNR) Reports Fiscal Fourth Quarter and Full Year 2023 Results
GTHX

GuruFocus.com

7 months ago

Limoneira Co (LMNR) Reports Fiscal Fourth Quarter and Full Year 2023 Results

GTHX

Business Wire

7 months ago

First Trust Senior Floating Rate Income Fund II Declares its Monthly Common Share Distribution of $0.097 Per Share for January

Bowman Ranked #3 on Forbes’ List of Most Successful Small Cap Companies in America
GTHX

Business Wire

7 months ago

Bowman Ranked #3 on Forbes’ List of Most Successful Small Cap Companies in America

Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Fourth Quarter of 2023
GTHX

GlobeNewswire

7 months ago

Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Fourth Quarter of 2023

Insider Sell: COO Michael Bruen Sells 5,000 Shares of Bowman Consulting Group Ltd (BWMN)
GTHX

GuruFocus.com

7 months ago

Insider Sell: COO Michael Bruen Sells 5,000 Shares of Bowman Consulting Group Ltd (BWMN)

5 Stocks to Boost Your Portfolio as Fed Keeps Rate Unchanged
GTHX

Zacks

7 months ago

5 Stocks to Boost Your Portfolio as Fed Keeps Rate Unchanged

OCM Growth Holdings LLC Sells Over Half a Million Shares of Runway Growth Finance Corp
GTHX

GuruFocus.com

7 months ago

OCM Growth Holdings LLC Sells Over Half a Million Shares of Runway Growth Finance Corp

Insider Sell Alert: Chief Medical Officer Rajesh Malik Offloads Shares of G1 Therapeutics Inc
GTHX

GuruFocus.com

7 months ago

Insider Sell Alert: Chief Medical Officer Rajesh Malik Offloads Shares of G1 Therapeutics Inc

Pleasing Signs As A Number Of Insiders Buy Shyft Group Stock
GTHX

Simply Wall St.

8 months ago

Pleasing Signs As A Number Of Insiders Buy Shyft Group Stock

G1 Therapeutics (NASDAQ:GTHX) adds US$67m to market cap in the past 7 days, though investors from five years ago are still down 90%
GTHX

Simply Wall St.

8 months ago

G1 Therapeutics (NASDAQ:GTHX) adds US$67m to market cap in the past 7 days, though investors from five years ago are still down 90%

G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer Therapy
GTHX

GlobeNewswire

8 months ago

G1 Therapeutics Presents New Post Hoc Analyses Indicating That Patients Who Previously Received Trilaciclib Have Improved Overall Survival with Subsequent Anticancer Therapy

Strength Seen in Capstar Financial (CSTR): Can Its 5.4% Jump Turn into More Strength?
GTHX

Zacks

8 months ago

Strength Seen in Capstar Financial (CSTR): Can Its 5.4% Jump Turn into More Strength?

Luxoft and MicroVision Join Forces to Enhance ADAS Automated Testing at Scale
GTHX

ACCESSWIRE

8 months ago

Luxoft and MicroVision Join Forces to Enhance ADAS Automated Testing at Scale

Zumiez's (ZUMZ) Q3 Loss Narrower Than Expected, Revenues Down
GTHX

Zacks

8 months ago

Zumiez's (ZUMZ) Q3 Loss Narrower Than Expected, Revenues Down

Zhihu Inc. (NYSE:ZH) Q3 2023 Earnings Call Transcript
GTHX

Insider Monkey

8 months ago

Zhihu Inc. (NYSE:ZH) Q3 2023 Earnings Call Transcript

G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium
GTHX

GlobeNewswire

8 months ago

G1 Therapeutics Announces Upcoming Presentation at the 2023 San Antonio Breast Cancer Symposium

14 Most Undervalued Industrial Stocks To Buy According To Hedge Funds
GTHX

Insider Monkey

8 months ago

14 Most Undervalued Industrial Stocks To Buy According To Hedge Funds

Miller Industries, Inc. (NYSE:MLR) Stock Goes Ex-Dividend In Just Four Days
GTHX

Simply Wall St.

8 months ago

Miller Industries, Inc. (NYSE:MLR) Stock Goes Ex-Dividend In Just Four Days

Favourable Signals For Zevra Therapeutics: Numerous Insiders Acquired Stock
GTHX

Simply Wall St.

8 months ago

Favourable Signals For Zevra Therapeutics: Numerous Insiders Acquired Stock

Urgent – Food Recall Because of Potential Undeclared Allergen Due to Mislabel
GTHX

GlobeNewswire

8 months ago

Urgent – Food Recall Because of Potential Undeclared Allergen Due to Mislabel

First Trust Senior Floating Rate Income Fund II Declares its Monthly Common Share Distribution of $0.097 Per Share for December
GTHX

Business Wire

8 months ago

First Trust Senior Floating Rate Income Fund II Declares its Monthly Common Share Distribution of $0.097 Per Share for December

Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company
GTHX

GlobeNewswire

8 months ago

Zevra Therapeutics Completes Acquisition of Acer Therapeutics in its Journey to Become a Leading Rare Disease Company

Forrester Research, Inc.'s (NASDAQ:FORR) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
GTHX

Simply Wall St.

8 months ago

Forrester Research, Inc.'s (NASDAQ:FORR) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Miller Industries to Host 1x1 Meetings with Investors at the Southwest IDEAS Investor Conference
GTHX

PR Newswire

8 months ago

Miller Industries to Host 1x1 Meetings with Investors at the Southwest IDEAS Investor Conference

First Trust Advisors L.P. Announces Portfolio Manager Update for First Trust Senior Floating Rate Income Fund II and First Trust High Yield Opportunities 2027 Term Fund
GTHX

Business Wire

8 months ago

First Trust Advisors L.P. Announces Portfolio Manager Update for First Trust Senior Floating Rate Income Fund II and First Trust High Yield Opportunities 2027 Term Fund

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2023 Earnings Call Transcript
GTHX

Insider Monkey

9 months ago

Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2023 Earnings Call Transcript

GTHX

Thomson Reuters StreetEvents

9 months ago

Q3 2023 Kaltura Inc Earnings Call

Kaltura Announces Financial Results for Third Quarter 2023
GTHX

GlobeNewswire

9 months ago

Kaltura Announces Financial Results for Third Quarter 2023

Share on Social Networks: